Clinical Trials
10 trialsNCT06790420 2026-05-15
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
NCT02536664 2023-04-18
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Hoffmann-La Roche
Completed
NCT01178086 2018-10-05
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Hoffmann-La Roche
Completed
NCT01609023 2018-06-26
CaLLypso
Hoffmann-La Roche
Completed
NCT02472756 2017-08-01
REFLECT 2
Hoffmann-La Roche
Completed
NCT01613027 2016-10-24
An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis
Hoffmann-La Roche
Completed
NCT01641952 2016-08-17
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
Hoffmann-La Roche
Completed
NCT02316613 2016-02-25
Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
Hoffmann-La Roche
Completed
NCT02486952 2016-02-22
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Hoffmann-La Roche
Completed
NCT02461290 2015-09-30
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Hoffmann-La Roche
Completed